Recent Advances in Adjuvant Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer

J Clin Oncol. 2022 Nov 10;40(32):3673-3676. doi: 10.1200/JCO.22.00702. Epub 2022 Jun 29.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use
  • Breast Neoplasms* / drug therapy
  • Breast Neoplasms* / metabolism
  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Receptor, ErbB-2 / metabolism
  • Receptors, Estrogen / metabolism
  • Receptors, Progesterone
  • Triple Negative Breast Neoplasms* / drug therapy

Substances

  • ERBB2 protein, human
  • Receptors, Estrogen
  • Receptor, ErbB-2
  • Receptors, Progesterone
  • Antineoplastic Agents, Hormonal